Congress Asset Management’s Relay Therapeutics RLAY Stock Holding History

Congress Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Buy	626,141 +7,203	+1%	+$105K	0.07%	207
2026 Q1	$6.16M	Buy	618,938 +204,771	+49%	+$1.83M	0.04%	240
2025 Q4	$3.5M	Buy	414,167 +5,325	+1%	+$38K	0.02%	251
2025 Q3	$2.13M	Buy	408,842 +252,142	+161%	+$961K	0.01%	278
2025 Q2	$542K	Buy	156,700 +498	+0.3%	+$1.48K	﹤0.01%	339
2025 Q1	$409K	Sell	156,202 -1,283	-0.8%	-$5.03K	﹤0.01%	334
2024 Q4	$649K	Buy	157,485 +11,061	+8%	+$60.2K	﹤0.01%	335
2024 Q3	$1.04M	Sell	146,424 -1,186	-0.8%	-$8.86K	0.01%	298
2024 Q2	$962K	Sell	147,610 -1,472	-1%	-$10.1K	0.01%	299
2024 Q1	$1.24M	Buy	149,082 +2,108	+1%	+$20.6K	0.01%	292
2023 Q4	$1.62M	Buy	146,974 +540	+0.4%	+$4.56K	0.01%	302
2023 Q3	$1.23M	Buy	146,434 +207	+0.1%	+$2.23K	0.01%	298
2023 Q2	$1.84M	Buy	+146,227	New	+$1.82M	0.02%	287

Other funds holding RLAY

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return